Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaëlle Lescuyer

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Bulletin Du Cancer|May 21, 2022
[hPG<sub>80</sub> and cancer: A new blood biomarker in development for patient monitoring]Benoit You, Eric Assenat, Léa Payen, et al.
FEBS Open Bio|January 31, 2025
Pharmacological effects of osimertinib on a chicken chorioallantoic membrane xenograft model with the EGFR exon-19-deleted advanced NSCLC mutationDavid Barthélémy, Arnaud Vigneron, Xavier Rousset, et al.
Molecular Diagnosis & Therapy|March 4, 2021
Routine Molecular Screening of Patients with Advanced Non-SmallCell Lung Cancer in Circulating Cell-Free DNA at Diagnosis and During Progression Using OncoBEAM<sup>TM</sup> EGFR V2 and NGS TechnologiesJessica Garcia, Arnaud Gauthier, Gaëlle Lescuyer, et al.
The Journal of Molecular Diagnostics : JMD|September 27, 2025
Analytical Validation of a Pan-Cancer Next-Generation Sequencing Assay for In-House Liquid Biopsy Testing: An International Multicenter StudyGaëlle Lescuyer, Alexandre Harlé, Hari Shankar Kumar, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Bulletin Du Cancer|May 21, 2022
[hPG<sub>80</sub> and cancer: A new blood biomarker in development for patient monitoring]Benoit You, Eric Assenat, Léa Payen, et al.
FEBS Open Bio|January 31, 2025
Pharmacological effects of osimertinib on a chicken chorioallantoic membrane xenograft model with the EGFR exon-19-deleted advanced NSCLC mutationDavid Barthélémy, Arnaud Vigneron, Xavier Rousset, et al.
Molecular Diagnosis & Therapy|March 4, 2021
Routine Molecular Screening of Patients with Advanced Non-SmallCell Lung Cancer in Circulating Cell-Free DNA at Diagnosis and During Progression Using OncoBEAM<sup>TM</sup> EGFR V2 and NGS TechnologiesJessica Garcia, Arnaud Gauthier, Gaëlle Lescuyer, et al.
The Journal of Molecular Diagnostics : JMD|September 27, 2025
Analytical Validation of a Pan-Cancer Next-Generation Sequencing Assay for In-House Liquid Biopsy Testing: An International Multicenter StudyGaëlle Lescuyer, Alexandre Harlé, Hari Shankar Kumar, et al.
Pageof 1